Inventor · disambiguated record
Brent Mckenzie
Also filed as: MCKENZIE BRENT · MCKENZIE BRENT S · MCKENZIE BRENT STEVEN
7 granted patents·5 pending applications·32 citations·filing 2002–2014
79Inventor score
Files withCSL LTD2BOWMAN EDWARD P1CSL BEHRING GMBH1JENKINS BRENDAN J1LUDWIG INST FOR CANCER RES LTD1
Top patents by PatentIndex Score
12 records- 0183US8518888B2Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11RJENKINS BRENDAN J·Filed 2009·Granted Aug 27, 2013·22 cites·6 claims
- 0280US8349575B2Relay vaccineQUEENSLAND INST MED RES·Filed 2011·Granted Jan 8, 2013·7 cites·3 claims
- 0369US9957329B2Factor XII inhibitors for the treatment of neurological inflammatory disordersCSL BEHRING GMBH·Filed 2013·Granted May 1, 2018·3 cites·14 claims
- 0459US2010135998A1Combination therapy for treatment of immune disordersSCHERING CORP·Filed 2008·Application pending·0 cites
- 0554US2013287775A1Combination therapy for treatment of immune disordersMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 0652US9352038B2Treatment of neurological conditionsCSL LTD·Filed 2014·Granted May 31, 2016·0 cites·7 claims
- 0752US9211329B2Method of treating inflammatory bowel diseaseCSL LTD·Filed 2012·Granted Dec 15, 2015·0 cites·10 claims
- 0847US2006121031A1Relay vaccineMCKENZIE BRENT S·Filed 2004·Application pending·0 cites
- 0946US2013302277A1Method of treatmentLUDWIG INST FOR CANCER RES LTD·Filed 2013·Application pending·0 cites
- 1045US2012156699A1Pathogenic TH17 Cells; related reagents and methodsBOWMAN EDWARD P·Filed 2012·Application pending·0 cites
- 1138US9364534B2Treatment of neurological conditionsMCKENZIE BRENT STEVEN·Filed 2010·Granted Jun 14, 2016·0 cites·7 claims
- 1237US8097430B2Antigen targetingMCKENZIE BRENT·Filed 2002·Granted Jan 17, 2012·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Brent Mckenzie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →